This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Best Growth Stocks to Buy for October 5th
by Zacks Equity Research
URI, HHS and OWL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 5, 2022.
Harte-Hanks (HHS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Harte-Hanks (HHS) closed at $11.21, marking a +0.72% move from the previous day.
Best Growth Stocks to Buy for October 4th
by Zacks Equity Research
HHS, PSTG and BCC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 4, 2022.
Best Growth Stocks to Buy for September 29th
by Zacks Equity Research
DINO, HHS and PERI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 29, 2022.
Harte-Hanks (HHS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Harte-Hanks (HHS) closed at $11.40, marking a +0.44% move from the previous day.
Best Growth Stocks to Buy for September 27th
by Zacks Equity Research
HHS, NFG and PERI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 27, 2022.
Is Harte Hanks (HHS) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Best Growth Stocks to Buy for September 23rd
by Zacks Equity Research
PERI, HHS and URI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 23, 2022.
Best Growth Stocks to Buy for September 21st
by Zacks Equity Research
HHS, TFII and URI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 21, 2022.
Harte-Hanks (HHS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Harte-Hanks (HHS) closed the most recent trading day at $11.96, moving -1.64% from the previous trading session.
Is Blucora (BCOR) Outperforming Other Business Services Stocks This Year?
by Zacks Equity Research
Here is how Blucora (BCOR) and Harte-Hanks (HHS) have performed compared to their sector so far this year.
Best Growth Stocks to Buy for September 19th
by Zacks Equity Research
PSTG, HHS and HCCI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 19, 2022.
Best Growth Stocks to Buy for September 15th
by Zacks Equity Research
LNG, HHS and HCCI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 15, 2022.
Best Growth Stocks to Buy for September 13th
by Zacks Equity Research
HHS, PERI and HCCI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 13, 2022.
Is Harte Hanks (HHS) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Reasons to Add Harte Hanks (HHS) Stock to Your Portfolio
by Zacks Equity Research
Harte Hanks (HHS) is currently investing in people and technology for revenue expansion.
Has Harte Hanks (HHS) Outpaced Other Business Services Stocks This Year?
by Zacks Equity Research
Here is how Harte-Hanks (HHS) and GEE Group Inc. (JOB) have performed compared to their sector so far this year.
Zacks Industry Outlook Highlights The Interpublic Group, Harte Hanks and Direct Digital
by Zacks Equity Research
The Interpublic Group, Harte Hanks and Direct Digital are part of Zacks Industry Outlook article.
3 Stocks to Watch From the Thriving Advertising & Marketing Industry
by Shuvra Shankar Dey
The Zacks Advertising and Marketing industry's prospects look good on healthy manufacturing and service activities. IPG, HHS and DRCT are likely to be industry frontrunners on digital marketing surge and client-centric strategies.
Will Harte-Hanks (HHS) Gain on Rising Earnings Estimates?
by Zacks Equity Research
Harte-Hanks (HHS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Here's Why Harte-Hanks (HHS) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does Harte-Hanks (HHS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Should Value Investors Buy Harte Hanks (HHS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Harte Hanks, Inc. (HHS) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Harte-Hanks (HHS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Are Business Services Stocks Lagging Harte Hanks (HHS) This Year?
by Zacks Equity Research
Here is how Harte-Hanks (HHS) and Instructure Holdings (INST) have performed compared to their sector so far this year.
Best Value Stocks to Buy for August 17th
by Zacks Equity Research
OROVY, TNP, and HHS made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 17, 2022.